Publication | Open Access

Structure–activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: Development of potential substrate-specific ERK1/2 inhibitors

Structure–activity RelationshipMolecular PharmacologyMedicinal ChemistryDrug TargetBiochemistryMedicineNatural SciencesRational Drug DesignAnti-cancer AgentPharmacologyPharmaceutical ChemistryInhibitory ActivityDrug Discovery